# Post-marketing Surveillance Study of Invasive Mycosis With Posaconazole (Study P04641)

> **NCT00726609** · — · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 214 (actual)

## Conditions studied

- Mycoses

## Interventions

- **DRUG:** Posaconazole

## Key facts

- **NCT ID:** NCT00726609
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2006-01
- **Primary completion:** 2008-07
- **Final completion:** 2008-07
- **Target enrollment:** 214 (ACTUAL)
- **Last updated:** 2015-03-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00726609

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00726609, "Post-marketing Surveillance Study of Invasive Mycosis With Posaconazole (Study P04641)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00726609. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*